Skip to content
About
Management
Board of Directors
Scientific Advisory Board
Therapeutic Areas
Pipeline
OLX07010 in Rare Tauopathies
OLX07010 Alzheimer’s
Technology
MOA
Patents
News & Publications
Partners and Collaborators
Contact Us
Menu
Oligomerix Awarded 1.98 Million NIH SBIR-Phase IIb Grant
Home
>
News
>
Oligomerix Awarded 1.98 Million NIH SBIR-Phase IIb Grant
Print
Oligomerix
>
News
>
Oligomerix Awarded 1.98 Million NIH SBIR-Phase IIb Grant
Oligomerix Awarded 1.98 Million NIH SBIR-Phase IIb Grant
Post navigation
Previous Post
Oligomerix Relocates to Albert Einstein College of Medicine Campus
Next Post
Oligomerix to Participate in the NIH Innovation Zone at 2019 BIO International Convention
vera
View posts by vera
Leave a Reply
Cancel reply
You must be
logged in
to post a comment.
Scroll to top
close ×
